Baricent 2 (Baricitinib 2 mg)

Baricent 2 (Baricitinib 2 mg) is a JAK inhibitor used for the treatment of moderate to severe rheumatoid arthritis in adults. As a generic version of Olumiant, it provides effective therapy at a significantly lower cost, making it a reliable and affordable long-term treatment option.

Overview

As a generic alternative to Olumiant, Baricent 2 (Baricitinib 2 mg) provides comparable clinical effectiveness at a significantly lower cost, making it a reliable and affordable option for long-term treatment.

Indications

Adults with moderate to severe rheumatoid arthritis
Patients who have had an inadequate response to TNF inhibitor therapies

Dosage & Administration

Recommended dose: 2 mg once daily
May be used as monotherapy or in combination with methotrexate or other DMARDs

Limitations of Use

Do not use with other JAK inhibitors
Avoid combination with biologic DMARDs
Avoid potent immunosuppressants such as azathioprine or cyclosporine

Warnings & Precautions

Anemia: Avoid initiation if hemoglobin < 8 g/dL
Lymphopenia: Avoid use if ALC < 500 cells/mm³
Neutropenia: Avoid use if ANC < 1000 cells/mm³

Possible Side Effects

Upper respiratory tract infections
Viral infections such as cold sores or shingles
Nausea

Cost & Savings

Baricent 2 is typically available at up to 80–90% lower cost compared to branded Olumiant in the USA and other markets.

Why Choose Baricent 2 from India

Manufactured in WHO-GMP certified facilities
Export-quality standards
Significant cost advantage
Reliable worldwide shipping

Prescribing Information

Refer to official FDA prescribing information or consult a qualified healthcare provider before use.